Although we have identified potential genetic targets and expression patterns through machine learning algorithms and single‐cell expression analysis, functional validation through in vivo studies and clinical trials is necessary to confirm their roles in glioma and CHD. This evidence concerns the gene CHDH and central nervous system cancer.